Although there have been few studies on EphA3 and PCa prognosis, in mesenchymal glioblastoma, hepatocellular carcinoma,10 gastric carcinoma,12 and multiple myeloma, it has been confirmed that high EphA3 expression is associated with a poor prognosis. This evidence concerns the gene EPHA3 and plasma cell myeloma.